Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
INDOCO On Other Exchanges
Symbol
Exchange
INDOCO is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for indoco remedies ltd (INDOCO)

Year over year, Indoco Remedies Limited has been able to grow revenues from 7.3B INR to 8.5B INR. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 35.64% to 16.40%. This was a driver that led to a bottom line growth from 579.8M INR to 828.1M INR.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2012
Restated
INR
Mar 31
2013
Restated
INR
Mar 31
2014
INR
Mar 31
2015
Press
Release

INR
4 Year
Trend
Revenues5,687.76,307.97,326.18,522.1
Other Revenues--10.110.4--
TOTAL REVENUES5,687.76,318.07,336.58,522.1
Cost of Goods Sold2,784.22,953.73,100.33,004.4
GROSS PROFIT2,903.53,364.34,236.25,517.7
Selling General & Admin Expenses, Total1,735.12,073.12,611.31,397.5
R&D Expenses160.2178.8208.0216.7
Depreciation & Amortization, Total192.5237.2309.0470.9
Other Operating Expenses151.3168.8197.52,248.4
OTHER OPERATING EXPENSES, TOTAL2,239.12,657.83,325.84,333.5
OPERATING INCOME664.4706.5910.51,184.2
Interest Expense-58.5-84.2-94.8-105.8
Interest and Investment Income15.34.76.9--
NET INTEREST EXPENSE-43.2-79.5-87.9-105.8
Currency Exchange Gains (Loss)-95.6-126.4-86.1--
Other Non-Operating Income (Expenses)-12.1-14.4-13.317.1
EBT, EXCLUDING UNUSUAL ITEMS513.5486.2723.11,095.5
Gain (Loss) on Sale of Assets-0.9-0.70.0--
EBT, INCLUDING UNUSUAL ITEMS512.7485.5723.21,095.5
Income Tax Expense49.257.9142.8267.4
Minority Interest in Earnings---0.4-0.5--
Earnings from Continuing Operations463.4427.6580.3828.1
NET INCOME463.4427.2579.8828.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS463.4427.2579.8828.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS463.4427.2579.8828.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INDR:IN 359.80 INR -15.05

INDOCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajanta Pharma Ltd 1,547 INR -11.50
Unichem Laboratories Ltd 185.35 INR -0.75
View Industry Companies
 

Industry Analysis

INDOCO

Industry Average

Valuation INDOCO Industry Range
Price/Earnings 35.4x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 22.6x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOCO REMEDIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.